Compare Heron Therapeutics Inc (HRTX) vs Roblox Corp (RBLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Roblox Corp — how do they compare? Heron Therapeutics Inc trades at $0.47 (market cap $91.46M), while Roblox Corp trades at $53.13 (market cap $38.13B). The key difference: Roblox Corp is far larger — about 416.9× Heron Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| HRTX | RBLX | |
|---|---|---|
Market Cap | $91.46M | $38.13B |
Sector | Health | Media |
52-Week High | $1.96 | $141.56 |
52-Week Low | $0.39 | $41.30 |
Enterprise Value | $189.36M | $36.71B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
Roblox trades at $54.08, up 4.64% today, showing positive momentum despite a bearish technical signal. The company continues to demonstrate strong revenue growth with $4.89B in 2025, though it remains unprofitable with a -20.69% net margin. Recent product innovation includes the launch of 'Build,' an AI-powered game creation tool, while facing multiple class-action lawsuits alleging securities fraud between October 2025 and April 2026.
While analyst consensus remains positive with a $59.62 price target and 51% buy ratings, investors face significant risks from ongoing litigation and persistent profitability challenges. The stock's high P/B ratio of 85.65 suggests premium valuation despite negative returns on equity, creating a mixed investment case dependent on future margin improvement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
